We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Technique Detects Down Syndrome in Fetuses in Two Hours

By HospiMedica staff writers
Posted on 27 Aug 2007
A new technique enables pregnant women to know whether their fetus has Down syndrome in just a few hours.

Called FlashFISH, the new technique is a modification of the existing standard fluorescence in situ hybridization (FISH) test, which provides results in 24-48 hours. More...
Another procedure, called karyotyping, delivers results between eight and 21 days.

Both FlashFISH and the standard FISH involve inserting a needle through the pregnant woman's abdominal wall to draw amniotic fluid from the womb. The amniotic fluid comes from the membranous sac, which surrounds the embryo and contains genetic material from the fetus. The FlashFISH test requires only two ml of fluid compared with 5 ml needed for standard tests. Clinicians examine fetal cells in the fluid by maneuvering a molecular probe directly into the cells' nucleus. The probe is a tiny portion of DNA that can attach to a matching sequence in the fetal cell and identify whether it is abnormal.

The new procedure was developed by assistant Prof. Mahesh Choolani, from the department of obstetrics and gynecology, National University of Singapore (NUS; Singapore), and his laboratory team. Dr Choolani reported that FlashFISH matches the accuracy of the currently used standard FISH test. He added that it poses no additional risks to the mother and costs roughly the same amount as the currently used test.

Prof. Choolani said that the test has proved to be 99% accurate in detecting Down syndrome. The new technique carries the same risk of miscarriage--about one in 100--as the traditional tests because it involves inserting a needle into the womb.

The test particularly will be useful for women who become pregnant after age 35 because they are more at risk for having a child with Down syndrome. Prof. Choolani said that they had decided to develop a faster test because, Waiting for test results can cause a lot of anxiety in couples.


Related Links:
National University of Singapore

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Glucose Meter
StatStrip®
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.